ACS Publications journals have long published cutting-edge content exploring the applications of nanoscience and nanotechnology to clinical diagnostics, monitoring, and therapeutics. Four new collections from across ACS journals exhibit the breadth of this research.
Nanomedicine is a branch of medicine that uses nanoscience and nanotechnology to address clinical challenges. Nanomedicine applications operate in various disciplines, including drug delivery, vaccine development, diagnosis and imaging instruments, and wearable devices.
These four collections, featuring articles published across ACS Publications' portfolio of journals, explore the latest opportunities arising from these new technologies.
Browse the Collections
View the Collection
DNA & RNA Therapeutics
Nanoparticles are increasingly used as delivery systems for DNA and RNA therapeutics, enhancing their stability and efficiency. These carriers have the potential to advance gene therapies in areas such as cancer, genetic disorders, and infectious diseases.
View the Collection
Nanorobotics
Tiny machines that can move untethered throughout bodies present great potential in biomedicine. Recent advances in design and operation have increased usable applications for targeted drug delivery, precision diagnosis, and microsurgery, and even detoxification.
View the Collection
Nanotheranostics
Nanotheranostics—nanotechnology that combines diagnostic and therapeutic functionality—presents new frontiers for personalized medicine. New platforms in the field offer opportunities for guided focal therapy, including real-time monitoring of drug delivery to reduce side effects and increase efficacy.
View the Collection
Wearable Nanodevices
Intimate, wearable devices enable real-time monitoring of physiological conditions. Through wearable nanodevices, healthcare is moving toward predictive and personalized patient monitoring, transforming how we detect, treat, and prevent diseases in everyday life.
Introducing ACS Nano Medicine
ACS Nano Medicine, led by Editor-in-Chief Xiaoyuan (Shawn) Chen (National University of Singapore), will continue this great tradition by providing a journal focused on trailblazing research breakthroughs in the application of nanoscience and nanotechnology to clinical diagnosis and therapeutics.
